|
April. 01, 2021 |
|
|
April. 01, 2021 |
|
|
jRCTs032200430 |
Cochlear implantation for unilateral severe to profound hearing loss |
|
Cochlear implantation for unilateral hearing loss |
Iwasaki Satoshi |
||
International University of Health and Welfare Mita Hospital |
||
1-4-3 Mita, Minatoku, Tokyo |
||
+81-3-3451-8121 |
||
iwasakis@iuhw.ac.jp |
||
Iwasaki Satoshi |
||
International University of Health and Welfare Mita Hospital |
||
1-4-3 Mita, Minatoku, Tokyo |
||
+81-3-3451-8121 |
||
iwasakis@iuhw.ac.jp |
Recruiting |
April. 01, 2021 |
||
| 38 | ||
Interventional |
||
single arm study |
||
open(masking not used) |
||
historical control |
||
single assignment |
||
treatment purpose |
||
General criteria |
||
The patients with below situations were exclude from this study. |
||
| 6age old over | ||
| No limit | ||
Both |
||
Unilateral severe to profound sensorineural hearing loss |
||
The cochlear implantation is performed under general anesthesia. Same as standard cochlea implant surgeries for bilateral healing loss, an antromastoidectomy is performed, followed by an atticotomy and posterior tympanotomy and insert cochlear implant electrode to cochlea and fix implanted electrode and signal receiver. The implant system can be activated, after the |
||
For the primary endpoint, speech perception test by using 67S Japanese monosyllable word table under the SoNnh, SN+0dB noise condition (Japan Audiological Society 1967, 1957) is performed before operation and 12 months after CI fitting.Marked recovery is defined as the average improvement of CI intervention group is significantly better than that of non-treated historical control group (N=17, average improvement: 10.9%, standard deviation: 24.4) by t-test or Wilcoxon signed-rank test. |
||
As the secondary endpoints, the sound localization test and audiometric test using free field audiometry are performed before operation and 12 months after CI fitting. |
||
| MED-EL Japan | |
| Applicable |
| MED-EL Electro-Medizinische Gerate GmbHMedel GMBH | |
| Not applicable |
| Shinshu University Certified Review Board of Clinical Research | |
| 3-1-1 Asahi Matsumoto city, Nagano | |
+81-263-37-2572 |
|
| md_rinri@shinshu-u.ac.jp | |
| Approval | |
Nov. 06, 2019 |
No |
none |